The pharmaceutical industrys response to the novel coronavirus may not rescue its ailing reputation. But it will, apparently, be televised and the footage could nudge the publics perception of how the drug business works.
That, at least, is the thinking behind a 30-minute weekly show from the multinational drug company Johnson & Johnson being launched Tuesday. The eight-episode series, which will be broadcast live online, will focus on the companys efforts to find a vaccine for the virus that causes Covid-19. J&J hired journalist Lisa Ling, of CNNs This Is Life, to host the program.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis.Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
See original here:
Johnson & Johnson tries to turn vaccine development into reality TV - STAT
Recommendation and review posted by G. Smith
